LGALS3 and cancer: Studies have shown that serum levels of Gal-3 are increased in individuals with HNSCC compared to those of controls, and its expression in individuals with risk factors for this type of cancer has been associated with an approximately 3-fold increased risk of developing HNSCC [6,105].